New Spotted Fever Group Rickettsia Isolate, Identified by Sequence Analysis of Conserved Genomic Regions

Dar Klein1, Adi Beth-Din1, Regev Cohen2,3

  • 1Israel Institute for Biological Research, P.O. Box 19, Ness-Ziona 74100, Israel.

Insights

This study identified a novel spotted fever group (SFG) Rickettsia strain in Israeli patients, challenging the assumption that only the Israeli SFG (ISF) strain causes disease. This finding necessitates updated diagnostic approaches for SFG rickettsiosis.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • Spotted fever group (SFG) rickettsiosis presents with diverse clinical manifestations, complicated by various virulent Rickettsia species.
  • Current diagnostics in Israel assume only Rickettsia conorii israelensis (ISF) is pathogenic, overlooking other SFG strains.
  • Recent tick studies indicate the presence of diverse SFG strains in Israel and surrounding regions.

Purpose of the Study:

  • To differentiate between ISF and non-ISF SFG strains in clinical samples from Israeli patients.
  • To identify and characterize novel SFG Rickettsia species circulating in Israel.

Main Methods:

  • Molecular analysis of SFG-positive clinical samples from Israeli patients.
  • Comparison of identified Rickettsia isolates against the NCBI database for species identification.

Main Results:

  • Identification of a novel Rickettsia isolate from three independent clinical samples.
  • The new isolate represents an unknown SFG member, distinct from all known Rickettsia species in the NCBI database.
  • This discovery challenges the current diagnostic paradigm in Israel.

Conclusions:

  • The existence of previously unrecognized SFG Rickettsia strains in Israel necessitates a re-evaluation of diagnostic strategies.
  • This finding has significant implications for the accurate diagnosis and treatment of SFG rickettsiosis in the region.